In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

Feeling less stigma — not losing weight — was linked to better mental health, eating behaviors and weight loss after ...

Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said ...

Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ...

Welcome back, everyone. This is the third installment in a weekly feature which was borne out of my weight loss journey this ...

Madhuri, a fitness blogger, demonstrated the transformative power of walking by taking 10,000 steps daily for 21 days, ...